A single microdose of LSD produces noticeable effects for about 4 hours, with the peak hitting around 2.5 hours after you take it. Psilocybin microdoses follow a shorter timeline, clearing your system faster due to a shorter half-life. But “how long does microdosing last” has several layers: the immediate effects you feel that day, the subtle afterglow that lingers for days afterward, and the deeper biological changes that may persist for weeks after a dosing cycle ends.
Acute Effects: What You Feel on Dose Day
In a controlled clinical study, a 10-microgram dose of LSD (a standard microdose) produced measurable subjective effects starting about 1.1 hours after ingestion, peaking at 2.5 hours, and fading by 5.1 hours. That gives you roughly a 4-hour window of active effects. A 5-microgram dose, on the lower end, produced no significant effects compared to placebo, which suggests there’s a threshold below which you won’t feel much of anything.
Psilocybin works on a tighter schedule. The active compound has a half-life of about 3 hours, meaning your body eliminates it considerably faster than LSD. LSD has an initial half-life of around 3.6 hours but a slower terminal elimination phase stretching to roughly 9 hours, which is why its effects linger longer. For psilocybin microdoses (typically under 3 mg of pure psilocybin, or about 0.3 to 0.5 grams of dried mushrooms), most people report effects lasting 3 to 4 hours.
Several factors influence exactly how long you’ll feel the effects. Your liver enzymes, particularly two key enzyme families involved in breaking down psilocin, vary significantly from person to person due to genetic differences. Some people are fast metabolizers and will process a microdose quickly, while others break it down more slowly. Whether you’ve eaten recently also matters: food in your stomach delays absorption because the compound has to work through your digestive system before reaching your bloodstream. Medications that affect these same liver enzymes can also speed up or slow down the process.
The Afterglow: Effects Between Doses
Beyond the hours when the substance is active in your body, many people report a residual positive effect on the days following a microdose. This phenomenon, known as the “psychedelic afterglow,” was first described in the 1960s and refers to subtle improvements in mood, openness, or cognitive flexibility that persist after the drug itself has been eliminated.
Research on full-dose psychedelic experiences shows that subacute effects typically last from days up to a few weeks, with the most consistent effects observed in the 3 to 14 day window after use. These effects then gradually fade over 2 to 4 weeks. While most afterglow research has focused on full doses rather than microdoses specifically, the same biological mechanisms are at play, and the afterglow is the entire rationale behind spacing out microdoses rather than taking them daily.
This is why the most popular microdosing schedule, outlined by researcher James Fadiman, follows a three-day cycle: one day on, two days off. The idea is that each microdose produces a residual effect lasting one to two days afterward, so you’re still benefiting on your “off” days. By the third day, those residual effects have faded and it’s time for the next dose.
Why You Can’t Just Take It Every Day
Tolerance builds remarkably fast with psychedelics. In animal studies, a single dose of a psychedelic compound reduced the brain’s response to a second dose given just 24 hours later. After four consecutive days of dosing, the behavioral response dropped by roughly 50%. This happens because the brain rapidly reduces the number of available serotonin receptors that psychedelics act on, a process called downregulation. Essentially, your brain adjusts to the repeated stimulation by pulling those receptors offline.
This rapid tolerance is the biological reason behind every microdosing protocol’s built-in rest days. Without breaks, you’d need increasingly larger doses to get the same effect, which defeats the purpose. The two-day gap in the Fadiman protocol, or the two consecutive days off in other popular schedules, gives your receptors time to return to baseline sensitivity.
How Long a Full Microdosing Cycle Lasts
Most microdosing protocols run for 4 to 8 weeks before taking an extended break, though there’s no firm clinical consensus on the ideal cycle length. The Fadiman protocol suggests following the three-day cycle for several weeks, then pausing for two to four weeks to assess how you feel without it.
Another popular approach, associated with mycologist Paul Stamets, combines a psilocybin microdose with lion’s mane mushroom and niacin, taken on a different schedule. Stamets has described this as the most popular “stack” in the microdosing community, though clinical evidence specifically validating this combination is limited. The typical microdose in clinical trials ranges from 10 to 20 micrograms of LSD or under 3 milligrams of psilocybin (roughly 0.3 to 0.5 grams of dried mushrooms).
Longer-Lasting Biological Changes
Perhaps the most interesting dimension of “how long does microdosing last” involves changes at the cellular level that outlast both the drug’s presence and the afterglow period. Psychedelics promote neuroplasticity, the brain’s ability to form new connections and reorganize itself. In animal studies, repeated psychedelic administration increased levels of a key growth factor (BDNF) that supports the survival and growth of nerve cells, with elevated levels detected up to a month after treatment ended.
One study found that chronic low-dose LSD given every other day for 90 days increased the expression of plasticity-related genes in the prefrontal cortex of rats, and these changes were still measurable four weeks after dosing stopped. Behaviorally, animals showed improved motor function lasting up to 30 days after treatment ended. The structural changes observed, including increased complexity in nerve cell branching, outlasted the acute effects of the drug itself.
In human studies, a single dose of a psychedelic can increase circulating levels of that same growth factor, though results have been inconsistent across trials. The long-term effects of repeated microdosing on brain structure and connectivity in humans haven’t been directly measured yet, so the animal data remains the best window into how long these deeper biological effects persist. Based on what’s available, the neuroplastic benefits of a microdosing cycle likely extend for several weeks beyond the last dose, gradually fading as the brain settles into its new baseline.
Duration at a Glance by Substance
- LSD microdose (10–20 mcg): Effects begin around 1 hour, peak at 2.5 hours, and resolve by 5 hours. The drug remains detectable in blood for up to 12 hours, with metabolites appearing in urine for roughly 24 hours.
- Psilocybin microdose (0.3–0.5 g mushrooms): Faster onset and shorter duration, with an elimination half-life of about 3 hours for the active compound. Most effects resolve within 3 to 4 hours.
- Afterglow period: Subtle residual effects for 1 to 2 days after each dose, consistent with the spacing in popular protocols.
- Post-cycle biological effects: Neuroplasticity-related changes may persist for 2 to 4 weeks after a dosing cycle ends, based on animal research.